M. Kassiou et al., [H-3] A-69024 - A NON-BENZAZEPINE LIGAND FOR IN-VITRO AND IN-VIVO STUDIES OF DOPAMINE D1 RECEPTORS, Life sciences, 57(23), 1995, pp. 367-372
Citations number
13
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
[H-3]A-69024 has been prepared as a radioligand for studying the dopam
ine D-1 receptor. [H-3]A-69024 binds to rat striatal membranes with a
K-D = 14.3 +/- 3.2 nM (mean +/- SEM; n = 3) and B-max = 63.5 +/- 12.8
fmol/mg wet tissue (1.8 +/- 0.3 pmol/mg protein). This ligand binds to
only one site with a Hill coefficient close to unity. The in vivo bio
distribution of [H-3]A-69024 showed a high uptake in the striatum (5.9
%ID/g) at 5 min followed by clearance. As a measure of specificity, th
e striatum/cerebellar ratio reached a maximum of 6.7 at 30 min post-in
jection. Pre-treatment with the D-1 antagonist R(+)SCH 23390 (1 mg/kg)
reduced this ratio to unity. The dopamine antagonist (+)butaclamol an
d unlabeled A-69024 inhibited striatal uptake by 70 and 51%, respectiv
ely. Spiperone (D-2/5-HT2A) and ketanserin (5-HT2A/5-HT2C) at doses of
1 mg/kg had no inhibitory effect on [H-3]A-69024 uptake in the striat
um; however, increased uptake of [H-3]A-69024 by > 30% in the whole br
ain was observed. The selectivity and affinity of [H-3]A-69024 suggest
s that this non-benzazepine radioligand may be useful for in vitro and
in vivo studies of the dopamine D-1 receptor.